rfhg_28478.1

Basic information about the TSS

---

TSS ID: rfhg_28478.1 TSS ID(Version3): hg_29241.1 hg_29243.1 hg_29242.1 Species: human Chr: chr2		Start: 74529671 End: 74529774 Strand: -
Source datasets	FANTOM5|PRJNA615891|PRJDB5282|PRJNA597322|PRJNA4843412 |DRA013844|PRJNA401781|PRJNA548673
Protocol	CAGE|TIF-seq2|C1CAGE|STRIPE-seq|NETCAGE|SLIC_CAGE|RAMPAGE |oligo_capping|ReCappable-seq
TSS cluster detected*	12

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3142180,EH38E2010505)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000425118.5:0 ENST00000463900.5:0 ENST00000377526.4:0 ENST00000466894.5:0 ENST00000472800.1:0 NM_181575.5:0 NR_126511.2:0 NR_126510.2:0 BC001658:0 AK055566:0 CR749661:0 BC033646:0 AF100753:0 AF100754:0 AF165515:0 AK023983:0 AK293121:0 AK304886:0 AK310159:0 AK308231:0 AK301398:0 GeneID: 550 HGNC/MGI_ID: HGNC:891 UniProt_ID: A8KAQ6 B4DW71 B4E3W1 Q68CX8 Q9Y679 Nearer transcript ids and distances: AF100746:1 CU674818:40 CU689682:40 EU831790:42 EU831868:42 AB527869:42 LF207216:-190 MA442793:-190 view more...

Gene_name: AUP1 Gene_symbol: AUP1 Gene_synonyms: Gene_source: HGNC:891

TATA-Box annotation

---

Distance to TSS:	-16
Nearest PromoterID:	NM_181575
Entrez ID:	550
Nearest Unigene:	Hs.411480
Nearest Refseq:	NM_181575
Nearest Ensembl:	ENSG00000115307
Gene Name:	AUP1
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.116505
GC%:	0.711538
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@AUP1 p2@AUP1 p3@AUP1 p4@AUP1 p9@AUP1
Sample		p1@AUP1	p2@AUP1	p3@AUP1	p4@AUP1	p9@AUP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	62.92	5.45	2.53	1.17	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	74.25	5.87	2.43	1.01	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	68.48	5.59	1.74	1.16	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	70.69	7.07	1.46	1.87	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	79.19	8.55	3.37	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	68.03	5.62	2.91	1.36	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	138.36	9.15	3.92	3.70	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	92.04	8.72	3.88	2.66	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	107.50	12.40	4.27	1.28	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	94.48	9.85	10.43	6.96	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	93.78	5.66	3.64	6.06	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	91.07	15.45	2.85	5.69	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	50.13	1.29	0.16	0.48	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	46.46	1.35	0.45	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.47	0.88	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	45.77	1.76	0.50	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	40.19	1.53	1.31	0.66	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	46.40	0.00	0.00	0.42	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	25.06	0.53	0.53	0.00	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	48.74	1.20	1.05	0.75	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	47.71	0.53	0.27	0.40	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	50.92	1.04	0.35	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	41.36	1.16	0.39	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	44.65	0.97	0.49	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	52.11	0.77	0.26	0.00	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	62.04	1.90	0.63	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	43.96	0.55	0.55	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	50.22	0.94	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	49.75	1.45	0.16	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	40.17	1.09	0.36	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.06	1.88	1.05	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	53.14	1.56	0.78	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.36	0.42	1.27	0.21	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	35.96	1.32	0.82	1.15	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	45.63	0.93	0.56	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	53.46	1.53	0.57	0.57	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	49.46	1.23	0.41	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	47.95	1.01	0.40	0.60	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	48.08	1.89	0.54	1.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	45.37	0.96	0.24	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	48.46	1.88	0.47	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	37.92	1.17	0.29	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	53.15	0.42	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	50.00	1.22	0.70	0.52	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	51.80	1.81	1.00	1.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	49.09	0.93	0.23	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	48.22	0.96	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	43.22	0.60	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.76	1.91	0.24	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	45.90	1.01	0.40	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	35.46	0.82	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	37.58	2.00	0.67	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	44.36	1.06	0.35	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	43.08	0.66	0.33	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	14.26	0.84	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	18.83	0.92	0.00	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	39.22	0.65	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	38.54	0.64	1.28	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	31.75	0.31	0.00	0.00	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	51.47	0.00	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	44.86	2.24	1.68	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	22.29	2.39	0.00	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	28.88	0.00	0.34	1.02	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	45.49	0.65	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	42.24	1.42	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	29.74	0.49	0.49	0.49	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	44.13	0.99	0.50	0.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	38.00	0.94	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	29.81	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	41.14	0.31	0.31	0.93	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	51.98	0.92	0.31	0.61	0.31
Adipocyte - breast, donor1	11376-118A8	57.18	2.06	1.43	0.48	0.63
Adipocyte - breast, donor2	11327-117E4	41.07	1.28	0.80	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	51.40	1.53	1.40	0.51	0.89
Adipocyte - omental, donor2	11474-119C7	38.12	0.75	2.24	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	32.49	0.67	0.33	1.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	22.33	0.64	1.28	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	38.48	2.20	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	53.74	1.81	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	57.69	2.61	1.74	0.52	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	56.72	0.98	1.37	0.00	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	36.55	0.51	0.51	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	25.65	0.84	0.84	0.84	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	32.92	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	63.30	2.25	0.88	0.48	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	40.02	1.94	0.32	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	22.93	0.53	0.53	1.07	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	28.93	1.11	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	52.82	4.16	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	41.44	1.26	0.75	0.75	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	36.32	1.31	1.31	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	35.93	2.13	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	60.55	2.43	1.10	0.44	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	53.43	3.23	1.43	0.72	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	32.35	1.20	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	41.38	1.98	1.62	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.72	1.03	0.41	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	24.94	1.14	1.03	0.34	0.23
Anulus Pulposus Cell, donor2	11463-119B5	12.98	1.47	0.00	0.49	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	22.91	0.45	1.35	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	23.01	0.43	0.43	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	19.26	2.14	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	18.83	0.90	0.90	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	15.18	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	36.30	1.32	0.66	1.98	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	25.02	1.95	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	28.64	0.49	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	26.13	1.19	0.00	1.19	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	19.21	0.75	1.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	28.30	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	22.57	1.25	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	30.81	0.99	1.32	0.49	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	20.47	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	42.52	1.06	1.21	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.25	0.54	0.54	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	28.53	1.32	0.38	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	27.26	0.27	0.53	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	28.29	0.00	1.95	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.55	1.00	1.00	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	19.21	1.20	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	28.30	1.20	1.37	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.93	0.97	1.46	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	24.66	1.14	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	20.59	3.63	0.00	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	23.94	0.00	0.57	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	27.58	1.07	1.07	1.07	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	28.39	1.81	1.03	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	28.15	1.88	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	21.22	0.64	1.29	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	33.53	0.71	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	22.81	1.75	1.75	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	23.78	1.51	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	32.08	0.00	0.00	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	28.48	1.02	0.51	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	28.27	1.27	0.51	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	20.33	0.64	0.64	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	2.59	0.43	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	26.46	1.06	0.85	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.29	0.58	0.29	1.74	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	28.34	1.89	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.80	1.53	1.02	0.00	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	25.94	0.64	1.07	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.06	1.20	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	21.87	0.73	0.00	0.73	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	27.59	1.61	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	5.10	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.90	2.54	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	30.35	1.03	1.03	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	28.76	2.45	0.61	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	23.90	1.43	1.43	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	27.05	2.22	0.67	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	33.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	24.92	1.11	0.55	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	25.69	1.06	0.26	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	30.89	2.18	0.36	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	26.28	2.21	1.35	0.49	0.00
Astrocyte - cerebellum, donor2	11580-120F5	27.56	2.74	1.20	0.86	0.17
Astrocyte - cerebellum, donor3	11661-122F5	36.71	1.26	0.84	0.00	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	43.92	1.39	2.79	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	37.69	2.43	0.97	0.49	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	50.27	1.34	0.89	0.30	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	56.65	2.06	1.26	2.29	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	62.39	2.38	0.75	1.25	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	53.94	2.96	0.57	1.14	0.00
Basophils, donor1	12241-129G9	61.72	2.09	0.52	0.00	0.00
Basophils, donor2	12242-129H1	63.86	1.80	0.72	1.08	0.00
Basophils, donor3	12243-129H2	81.73	1.76	0.59	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	35.14	1.94	1.08	0.65	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	38.86	5.03	0.91	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	43.94	3.77	0.00	1.88	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	48.04	3.33	0.83	0.83	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	32.70	2.76	0.92	0.92	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	22.85	1.26	1.26	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	67.50	4.84	3.40	1.44	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	86.41	4.43	2.56	2.10	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	96.57	3.20	0.96	1.60	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	10.34	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	73.26	2.25	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	39.90	1.30	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	73.33	0.88	0.66	0.88	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	83.50	1.42	0.57	0.00	1.13
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	79.61	1.90	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	89.42	1.31	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	53.05	2.17	0.43	0.58	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	37.42	0.91	0.60	0.30	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	41.93	0.95	0.24	0.71	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	30.63	1.17	0.00	0.67	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.85	1.10	0.00	0.55	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	34.71	1.24	0.50	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	34.66	1.17	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.72	0.89	0.53	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	35.04	1.09	0.65	0.44	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	35.82	1.17	0.70	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.91	3.17	0.53	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	0.00	2.22	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	40.01	0.59	0.59	0.74	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	31.33	0.40	0.20	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	44.35	1.46	0.21	1.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	35.23	1.14	0.69	0.23	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	25.79	0.45	0.23	0.23	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	30.12	0.44	0.44	1.31	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	30.13	0.00	0.27	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	43.44	2.27	0.87	0.87	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	35.77	0.42	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	35.27	1.10	0.37	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	33.47	1.41	0.00	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	35.54	0.00	0.00	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	29.82	1.39	0.70	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	27.13	1.12	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	46.77	2.37	0.43	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	31.53	0.82	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	25.73	0.23	1.16	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	43.85	1.16	0.93	0.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	57.54	1.09	0.22	0.44	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	67.22	2.31	0.69	0.92	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	56.75	1.30	0.87	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	79.42	3.74	0.47	0.62	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	65.32	1.92	0.70	0.35	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	49.72	0.89	1.11	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	78.08	1.53	1.02	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	67.63	1.54	1.10	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	57.90	1.89	0.84	0.21	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	134.13	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	126.78	2.03	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	115.99	2.07	5.18	2.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	112.47	4.80	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	120.62	2.14	1.61	0.00	1.61
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	119.33	2.81	3.51	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	133.34	2.35	1.57	1.57	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	139.74	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	91.23	5.75	0.00	0.82	0.00
CD19+ B Cells, donor2	11624-122B4	83.42	1.45	0.73	1.45	0.00
CD19+ B Cells, donor3	11705-123B4	66.13	1.51	1.01	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	69.90	2.83	1.21	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	64.32	2.00	1.60	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	40.16	1.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	25.28	0.56	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	81.54	4.51	3.01	0.75	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	89.07	2.71	1.35	0.23	0.00
CD4+ T Cells, donor1	11225-116C1	81.05	0.36	0.36	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	58.17	0.61	1.22	1.22	0.00
CD4+ T Cells, donor3	11382-118B5	72.59	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	66.11	1.28	1.02	0.51	0.26
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	107.81	1.57	2.47	1.12	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	97.45	3.16	2.87	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	135.59	0.47	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	110.97	0.70	0.70	1.40	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	105.48	0.00	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	40.90	0.87	1.16	0.58	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	67.95	2.20	1.53	0.85	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	67.22	1.45	1.45	1.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	91.00	0.45	2.24	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	86.30	1.75	1.75	0.35	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	69.52	0.00	0.88	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	37.10	0.00	2.11	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	58.59	1.45	0.83	0.62	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	40.76	0.67	0.33	1.34	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	78.05	0.54	1.09	1.36	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	76.10	0.54	1.07	0.54	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	71.73	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	51.18	1.30	1.67	0.37	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	72.78	0.87	1.52	0.87	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	67.25	0.63	0.63	1.05	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	97.08	0.51	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	84.92	0.43	2.60	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	52.30	0.87	0.00	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	125.20	1.48	1.48	1.48	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	94.16	1.85	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	99.10	0.00	2.79	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	46.52	1.66	0.28	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	50.55	1.72	0.74	0.49	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	70.84	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	103.50	2.86	0.36	1.43	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	119.11	1.38	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	76.61	0.65	0.65	0.33	0.33
CD8+ T Cells, donor2	11307-117C2	67.20	0.75	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	86.10	0.00	1.26	0.76	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	51.61	5.51	2.98	0.92	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	48.17	5.27	0.96	1.20	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	40.49	2.74	1.64	1.09	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	36.63	3.30	1.80	0.60	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	45.12	4.80	1.92	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	40.93	4.78	3.41	1.36	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	48.45	3.91	3.48	1.30	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	51.32	4.21	2.90	0.53	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	51.83	3.99	1.41	1.41	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	46.49	4.53	1.81	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	49.39	3.49	1.45	1.16	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	45.83	5.06	1.33	0.80	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	38.08	5.25	0.44	2.19	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	44.63	2.73	1.37	3.19	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	35.80	2.24	2.24	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	51.50	3.96	2.16	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	50.35	4.03	1.73	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	54.45	4.71	0.94	1.65	0.24
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	58.94	6.02	1.27	2.22	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	50.13	4.31	2.77	0.92	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	55.78	4.49	3.85	1.60	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	54.69	6.12	3.06	1.15	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	47.29	5.12	3.15	1.18	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	36.31	3.03	4.54	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	76.28	8.03	0.80	3.21	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	68.54	7.69	2.10	2.10	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	65.11	4.01	1.00	2.00	1.00
Cardiac Myocyte, donor1	11525-119I4	5.48	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	28.16	0.49	0.99	0.99	0.00
Cardiac Myocyte, donor3	11686-122I3	29.57	0.84	0.42	0.11	0.00
Chondrocyte - de diff, donor1	11261-116G1	28.77	2.77	1.39	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	34.47	1.42	1.07	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	32.54	1.71	0.57	0.68	0.00
Chondrocyte - re diff, donor2	11339-117F7	73.41	3.58	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	38.01	3.24	0.81	0.81	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	28.35	1.49	1.03	0.11	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	23.73	2.14	0.43	0.00	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	30.62	1.33	0.35	0.53	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	51.26	1.38	1.10	0.46	0.28
Corneal Epithelial Cells, donor1	11526-119I5	51.60	2.42	0.88	0.22	0.00
Corneal Epithelial Cells, donor2	11606-120I4	35.27	4.55	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	49.85	1.53	0.26	1.02	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	61.91	2.97	1.16	0.33	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	66.55	2.21	0.95	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	82.82	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	63.93	3.02	0.97	1.94	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	66.62	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	73.12	0.65	0.65	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	45.01	0.00	0.97	0.97	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	58.54	3.34	1.00	0.33	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	35.79	1.17	0.59	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	39.31	2.55	0.00	0.85	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	23.59	1.57	0.00	1.18	0.00
Endothelial Cells - Artery, donor1	11264-116G4	35.20	3.20	0.58	0.58	0.29
Endothelial Cells - Artery, donor2	11341-117F9	45.17	3.29	0.94	0.94	0.00
Endothelial Cells - Artery, donor3	11413-118E9	69.77	3.51	1.93	0.70	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	38.57	3.55	1.11	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	38.34	1.83	1.22	0.91	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	28.19	1.13	1.13	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	18.13	1.78	0.00	1.49	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	36.97	0.52	1.56	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	33.46	0.99	0.43	0.14	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	22.81	0.80	0.80	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	18.87	4.72	1.57	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	49.08	2.61	0.99	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	24.33	1.74	0.87	0.87	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	37.86	1.47	0.61	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	48.91	4.55	1.14	2.28	0.00
Endothelial Cells - Vein, donor2	11344-117G3	57.98	1.40	0.00	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	46.16	3.45	1.10	0.79	0.00
Eosinophils, donor1	12244-129H3	106.73	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	49.51	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	53.50	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	32.25	2.44	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	2.08	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	25.86	0.41	1.23	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	20.36	1.53	0.55	1.09	0.44
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	12.46	1.95	1.41	0.33	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	32.14	1.94	0.73	0.85	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	64.96	2.87	2.32	0.55	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.30	0.42	0.32	0.11	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	30.04	0.26	0.00	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	31.89	1.66	0.66	0.33	0.00
Fibroblast - Cardiac, donor1	11268-116G8	28.12	2.27	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	33.35	2.27	0.76	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	54.10	3.00	1.89	1.10	0.32
Fibroblast - Cardiac, donor4	11452-119A3	42.74	1.52	1.21	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	25.51	1.27	0.51	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	30.47	1.97	0.91	0.76	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	24.12	1.07	0.54	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.00	0.43	0.00	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	36.62	4.39	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	80.03	1.15	1.61	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	35.79	0.51	1.02	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	28.88	1.88	1.17	0.23	0.23
Fibroblast - Dermal, donor2	11346-117G5	47.64	1.42	1.42	0.00	0.47
Fibroblast - Dermal, donor3	11418-118F5	48.60	1.21	1.09	0.48	0.60
Fibroblast - Dermal, donor4	11450-119A1	26.34	1.92	1.24	0.57	0.11
Fibroblast - Dermal, donor5	11454-119A5	35.24	3.31	0.17	0.52	0.00
Fibroblast - Dermal, donor6	11458-119A9	33.95	2.92	0.32	0.32	0.16
Fibroblast - Gingival, donor1	11237-116D4	44.98	1.87	1.04	0.21	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	22.53	1.31	0.26	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	44.54	1.58	0.40	0.26	0.00
Fibroblast - Gingival, donor3	11394-118C8	42.54	1.35	1.06	0.00	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	47.79	2.08	0.00	0.00	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	24.84	0.70	0.35	0.18	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	36.01	1.40	0.62	0.62	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	30.29	1.62	1.08	0.54	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	24.00	2.12	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	27.35	1.61	0.88	1.17	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	19.63	1.64	0.41	0.55	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	40.92	2.96	0.77	0.88	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	26.27	0.59	0.29	1.03	0.44
Fibroblast - Lung, donor1	11270-116H1	38.06	4.08	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	56.77	1.69	1.06	0.42	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	21.66	4.17	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	1.40	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	27.43	1.12	0.84	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	58.46	4.06	2.44	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	45.39	2.33	1.16	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	42.77	2.28	0.46	0.46	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	53.24	2.75	0.61	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	22.13	0.76	0.76	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.08	0.54	0.00	0.27	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.66	0.58	0.00	0.46	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	50.84	2.98	1.11	0.44	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.42	1.63	0.61	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.12	1.34	2.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	39.54	1.98	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	26.20	1.39	0.60	0.20	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	26.11	1.60	0.36	0.00	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	25.42	0.99	0.79	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	40.92	0.90	1.20	1.50	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	17.27	1.51	0.43	0.32	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.81	1.01	0.25	0.76	0.00
Fibroblast - skin normal, donor1	11553-120C5	28.22	1.48	1.15	0.00	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	109.88	2.21	2.01	1.00	0.40
Fibroblast - skin normal, donor2	11561-120D4	22.70	1.41	0.70	0.10	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	23.88	1.21	0.91	0.30	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	32.14	1.08	0.50	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	13.85	1.71	0.17	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	30.54	0.99	0.66	1.64	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	32.06	1.28	0.11	0.32	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	37.78	2.02	0.51	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	21.01	1.10	0.31	0.63	0.16
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	27.02	0.87	1.74	1.74	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	52.18	1.91	1.04	0.69	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	52.05	2.08	0.52	0.78	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	42.93	3.07	1.28	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	59.71	2.30	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	63.17	3.83	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	74.74	2.85	1.14	1.43	2.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.05	0.83	0.55	0.83	2.76
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	47.04	1.37	0.00	0.91	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	68.75	3.37	0.40	1.59	1.39
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	56.57	2.11	1.32	1.32	3.17
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	54.14	2.94	1.30	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	58.37	0.44	0.44	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	28.69	1.27	0.28	0.85	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.80	1.97	0.62	0.25	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.12	1.07	0.54	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	34.94	1.73	1.86	0.74	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	30.18	1.94	0.69	0.69	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	34.15	1.22	0.20	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	43.58	2.05	1.14	0.68	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	30.89	1.12	1.00	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	40.87	0.87	1.09	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	46.39	2.95	2.07	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	30.52	1.27	1.59	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.00	1.12	1.34	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	45.17	2.22	1.61	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	30.20	2.04	0.51	0.68	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	39.81	1.60	0.89	0.18	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	53.69	2.60	2.60	0.73	0.62
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	44.74	3.07	3.42	0.68	0.51
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	37.51	2.32	2.10	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	45.34	2.75	1.33	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	37.57	2.45	1.43	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	50.54	2.48	1.24	0.41	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.36	1.84	1.73	0.69	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	62.20	3.34	1.67	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	50.70	1.10	0.88	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	41.94	2.95	3.57	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.19	2.11	0.97	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	49.71	4.17	2.25	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	42.45	3.03	1.23	0.66	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.94	2.21	1.42	0.47	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	49.87	1.82	1.52	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	42.97	1.46	0.84	0.84	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	52.03	2.85	2.20	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.82	1.96	1.96	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	50.83	2.59	1.48	0.83	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	53.75	2.94	1.07	0.80	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	57.68	2.91	2.14	0.61	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	54.92	2.72	1.30	1.04	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	60.18	2.71	2.44	0.00	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	51.07	2.77	1.11	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	51.54	1.54	1.97	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	40.66	0.99	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.66	2.24	0.13	0.00	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	40.75	1.41	2.02	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	43.21	1.52	1.27	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	24.48	1.79	0.40	0.40	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	32.20	1.54	0.77	0.46	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.89	0.41	0.61	0.61	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	84.49	1.88	0.63	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	72.90	1.13	1.13	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	27.21	0.00	0.92	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	61.87	0.00	0.00	4.95	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	38.68	0.77	0.39	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	38.25	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	39.06	2.60	1.30	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	35.00	0.41	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	38.31	1.96	0.56	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	30.40	2.29	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	46.97	1.68	1.68	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	32.13	1.91	0.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	29.55	1.70	1.36	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	52.20	6.26	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	22.34	1.72	0.00	0.57	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	32.26	0.59	0.30	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	1.69	3.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	36.86	1.24	1.66	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	39.12	1.15	0.23	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	36.88	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	31.52	0.38	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	35.86	1.96	0.65	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	44.81	1.34	2.01	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.81	3.08	1.54	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	48.27	2.05	1.03	0.34	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	0.00	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	40.11	0.47	1.42	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	32.59	1.81	1.81	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.71	1.53	2.03	1.53	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	36.29	2.79	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	38.98	2.96	1.48	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	29.51	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	39.09	1.75	0.58	0.58	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	39.50	2.63	0.88	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	27.13	0.85	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	30.44	0.00	0.60	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	24.75	0.97	0.00	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	52.50	2.28	0.00	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	30.77	0.83	0.42	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	91.08	2.25	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	23.47	1.59	0.63	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	24.65	1.25	1.67	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	63.01	2.09	1.04	1.16	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	50.81	2.36	1.52	0.84	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	48.46	1.59	0.46	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	61.10	4.04	0.44	0.66	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	56.31	3.44	1.50	0.43	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	48.01	1.29	1.94	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	64.14	2.74	1.25	0.87	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	51.98	2.74	1.20	0.86	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	48.38	2.88	1.92	1.92	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	21.27	4.48	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	41.12	2.16	1.30	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.97	1.41	1.06	0.71	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	46.50	0.73	1.45	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	41.44	0.87	0.35	0.17	0.00
Hepatocyte, donor1	11523-119I2	53.27	1.21	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	64.64	2.15	2.15	1.08	1.08
Hepatocyte, donor3	11684-122I1	68.72	0.61	0.00	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	35.90	0.65	0.00	1.96	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	79.35	2.62	0.52	0.70	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	29.23	1.51	1.23	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	191.03	3.18	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	193.58	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	171.66	4.15	1.38	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	147.66	2.50	2.50	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	130.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	197.34	12.81	2.56	7.69	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	146.26	9.14	0.00	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	191.67	3.25	3.25	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	115.04	3.33	1.67	1.67	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	101.66	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	218.37	6.62	1.32	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	120.84	7.76	2.22	4.43	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	136.20	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	141.72	2.52	1.26	3.78	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	171.68	6.19	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	102.44	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	147.30	7.11	1.94	3.88	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	204.46	8.05	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	227.02	11.95	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	184.98	6.52	0.81	4.89	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	210.32	5.46	2.10	2.10	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	152.70	9.64	0.80	4.02	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	132.03	6.46	3.69	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	180.97	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	103.38	5.66	2.83	2.83	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	144.21	4.53	1.81	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	147.42	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	163.57	6.46	2.15	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	223.60	8.89	3.81	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	164.30	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	142.84	5.74	4.46	3.83	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	185.91	9.11	1.82	5.47	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	173.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	165.66	7.14	2.86	4.28	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	209.05	6.64	0.00	9.95	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	187.64	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	129.64	5.86	0.31	2.47	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	212.48	8.78	0.00	5.27	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	207.45	6.29	3.14	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	197.49	10.43	0.70	3.48	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	174.83	4.43	0.00	2.21	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	188.04	9.73	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	128.17	6.10	2.62	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	222.73	9.00	2.25	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	188.17	6.97	6.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	182.42	5.33	1.07	1.07	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	163.48	4.16	2.77	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	250.76	11.40	2.85	2.85	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	185.93	11.97	0.92	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	157.32	3.03	3.03	3.03	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	260.76	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	123.71	10.57	5.29	2.11	0.00
Keratinocyte - epidermal, donor1	11272-116H3	28.56	1.39	0.73	0.24	0.41
Keratinocyte - epidermal, donor2	11349-117G8	50.36	2.93	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	44.87	1.14	1.04	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	44.27	2.27	1.02	0.23	0.11
Keratocytes, donor1	11527-119I6	86.99	2.41	0.34	0.69	0.34
Keratocytes, donor2	11607-120I5	31.64	2.34	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	48.81	1.19	0.99	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	32.97	2.20	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	21.57	1.08	1.08	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	28.83	1.04	1.04	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	27.25	0.61	0.81	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	33.56	2.02	0.83	0.59	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	25.67	0.28	0.00	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	25.03	2.05	0.31	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	20.97	1.61	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	25.84	1.58	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	23.83	1.40	0.43	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	19.70	2.05	0.82	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.27	0.76	0.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	17.88	1.27	0.14	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.59	1.19	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	23.85	1.16	0.78	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	24.25	1.67	1.11	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	25.09	1.05	1.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	29.82	1.67	0.24	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.94	1.24	1.10	0.41	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.09	1.23	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	25.25	0.94	0.94	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	23.97	1.83	0.91	0.37	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.40	1.32	0.33	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	31.34	0.29	1.46	0.88	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	20.91	1.99	0.50	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.61	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	23.97	1.08	1.08	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	19.22	0.91	0.61	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	18.14	0.52	1.04	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	26.80	1.88	0.42	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.46	1.95	0.60	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	22.01	2.06	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	24.46	1.88	0.38	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	21.74	1.91	1.06	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.71	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.49	1.65	0.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	24.28	1.36	0.62	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.69	2.22	0.00	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	27.92	1.24	0.49	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	21.04	1.37	0.96	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	20.26	1.61	0.64	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.91	0.61	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	20.99	0.70	0.56	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.60	1.07	0.71	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	24.24	1.45	0.97	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	22.87	1.09	0.78	0.16	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	25.78	2.15	1.07	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	28.75	2.61	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.60	0.71	0.24	0.47	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	34.65	1.36	0.74	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	25.61	1.54	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	22.38	1.79	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	104.24	6.80	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.11	6.90	0.77	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	66.06	4.45	1.48	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	60.93	3.81	1.27	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	62.60	7.74	2.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	71.92	3.74	0.93	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	44.31	2.06	0.52	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	88.02	3.57	1.19	1.19	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	83.24	6.11	2.26	1.36	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	45.08	2.62	0.87	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	58.07	3.15	1.35	1.35	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	97.01	4.88	2.17	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	53.92	3.08	1.54	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	61.40	1.76	1.41	2.12	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	42.64	1.33	3.33	1.33	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	66.22	4.58	1.02	2.04	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	65.10	2.67	1.07	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	56.87	2.83	1.89	0.94	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	74.24	6.14	3.68	1.23	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	85.62	8.97	3.26	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	57.27	2.92	1.25	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	52.97	1.40	0.56	1.40	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	62.85	1.03	1.03	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	65.03	2.90	2.03	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	43.94	1.79	1.20	1.20	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	56.43	3.32	0.55	1.66	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	65.75	2.83	1.77	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	67.12	2.58	3.32	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	63.32	2.30	0.00	2.30	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	68.69	3.84	1.54	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	54.91	6.79	1.13	2.26	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	4.10	1.64	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	69.14	5.87	1.81	1.36	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	60.32	1.44	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	73.20	3.73	2.99	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	57.23	3.34	1.49	1.49	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	37.91	2.15	0.43	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	68.50	1.71	1.71	0.86	1.71
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	70.97	4.00	2.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	56.11	4.22	0.60	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	87.45	2.84	3.55	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	61.87	5.50	2.06	1.03	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	54.21	1.61	1.61	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	81.48	5.39	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	63.71	2.59	1.85	1.48	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	68.61	4.65	1.16	3.49	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	80.39	5.29	2.12	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	69.23	4.00	1.20	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	65.42	3.63	1.45	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	98.11	6.13	2.30	1.53	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	80.90	5.92	2.96	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	39.52	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	97.04	3.52	3.02	1.51	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	67.14	4.06	0.00	2.25	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	48.19	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	84.62	5.34	2.67	1.34	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	63.74	3.52	1.96	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	58.72	2.64	0.66	1.32	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	81.99	4.15	2.59	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	61.70	1.31	1.31	1.75	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	55.91	2.24	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	93.19	5.74	1.32	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	59.01	6.94	1.54	1.54	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	48.10	2.53	3.54	3.04	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	79.30	4.81	2.40	1.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	63.61	5.96	2.39	1.59	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	47.39	3.04	1.82	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	39.43	8.30	0.00	1.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	78.66	3.42	2.66	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	55.77	2.58	3.10	2.07	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	45.35	3.63	3.63	3.02	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	67.18	2.54	2.22	1.58	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	66.10	2.67	1.07	2.13	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	57.47	5.75	1.72	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	80.22	3.09	3.60	3.60	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	58.71	4.95	1.41	0.71	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	48.80	6.24	1.13	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	81.96	5.82	0.83	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	53.25	3.13	0.00	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	64.72	6.26	0.84	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	78.99	2.32	1.39	2.32	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	47.50	4.01	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	52.39	4.28	2.14	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	70.72	6.06	1.62	0.81	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	53.23	1.84	0.92	1.84	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	52.46	1.78	3.56	3.56	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	89.47	5.13	3.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	66.72	2.30	1.53	2.30	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	39.94	3.83	1.09	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	89.98	5.35	1.34	2.23	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	138.56	7.54	2.08	1.04	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	68.96	5.30	2.65	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	103.93	2.08	6.24	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	58.80	1.60	0.46	1.14	0.00
Macrophage - monocyte derived, donor2	11313-117C8	62.39	2.94	1.47	1.28	0.00
Macrophage - monocyte derived, donor3	11389-118C3	65.41	1.31	0.66	0.79	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	33.99	1.06	1.06	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	25.99	0.79	0.32	0.95	0.16
Mallassez-derived cells, donor3	11930-125I4	27.24	1.81	0.28	0.42	0.00
Mammary Epithelial Cell, donor1	11273-116H4	43.25	2.29	0.40	0.80	0.00
Mammary Epithelial Cell, donor2	11350-117G9	35.33	2.32	0.87	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	58.62	1.75	0.50	0.25	0.00
Mast cell - stimulated, donor1	11487-119E2	69.15	1.36	2.03	3.39	0.00
Mast cell, donor1	11563-120D6	55.37	2.70	1.41	0.43	0.32
Mast cell, donor2	11565-120D8	55.87	1.49	0.89	0.00	0.00
Mast cell, donor3	11566-120D9	77.44	2.03	1.80	1.58	0.90
Mast cell, donor4	11567-120E1	56.02	1.95	1.42	1.60	1.06
Mast cell, expanded and stimulated, donor5	11940-126A5	70.75	4.55	2.66	0.55	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	41.44	2.33	0.00	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	80.53	3.67	1.49	1.61	0.69
Mast cell, expanded, donor8	11941-126A6	72.64	2.01	1.17	3.01	1.17
Melanocyte - dark, donor1	11502-119F8	46.76	2.79	1.79	0.80	0.00
Melanocyte - dark, donor2	11582-120F7	30.80	1.38	1.73	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	92.00	4.71	3.19	0.43	0.00
Melanocyte - light, donor1	11274-116H5	94.73	4.47	3.29	0.24	1.18
Melanocyte - light, donor2	11351-117H1	88.72	4.09	4.78	0.68	0.68
Melanocyte - light, donor3	11423-118G1	83.25	5.20	0.87	0.87	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	94.13	4.89	3.54	0.31	0.73
Melanocyte, donor2 (MC+2)	12739-135I3	64.55	4.84	2.69	2.69	0.81
Melanocyte, donor3 (MC+3)	12837-137B2	46.07	3.48	2.41	0.80	0.54
Meningeal Cells, donor1	11493-119E8	32.01	3.23	1.24	0.12	0.12
Meningeal Cells, donor2	11573-120E7	33.01	0.44	0.44	0.44	0.00
Meningeal Cells, donor3	11654-122E7	44.58	1.79	0.82	0.41	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	38.21	2.00	0.57	0.29	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	34.82	0.81	0.70	0.40	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	90.68	2.63	2.63	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	58.87	5.23	3.92	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	81.09	4.31	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	25.62	0.64	1.27	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	22.62	0.00	0.00	0.00	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	47.47	3.08	0.66	0.88	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	48.22	1.46	1.46	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	48.08	3.89	0.82	0.41	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	9.42	0.69	0.14	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	49.44	0.37	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	20.53	0.66	0.66	0.13	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	34.72	0.00	0.30	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	37.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	24.34	1.28	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	67.34	4.61	1.42	0.71	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	25.64	0.63	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	38.46	2.90	1.45	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	50.12	1.59	0.27	0.80	0.00
Mesothelial Cells, donor2	12156-128G5	42.04	2.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	35.48	0.87	0.43	0.65	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	29.71	0.00	0.00	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	40.64	1.48	0.74	0.74	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	40.34	3.53	2.06	1.77	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	33.78	1.55	1.24	1.24	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	37.96	2.28	1.45	1.04	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	4.63	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	48.05	1.25	1.00	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	38.63	0.47	0.47	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	44.91	1.63	1.02	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	36.43	0.79	1.19	1.98	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	43.36	1.77	0.88	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	44.07	3.04	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	28.95	1.32	2.63	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	30.56	2.76	0.42	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	16.57	0.00	0.00	1.84	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	30.70	0.00	2.38	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	34.37	2.26	0.50	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	31.37	1.90	1.19	0.71	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.67	1.66	0.00	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	33.16	1.38	2.07	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.29	1.47	0.42	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	37.50	1.22	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	45.70	2.36	0.43	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	28.68	2.00	1.56	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	31.10	1.31	1.10	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	22.31	1.52	0.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	3.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	29.35	1.09	0.54	0.27	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	26.17	2.65	1.18	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	55.74	1.44	0.48	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	28.02	0.40	0.80	0.80	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	16.45	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	52.06	2.00	0.00	1.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	24.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	34.16	2.19	0.44	1.31	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	24.33	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	41.65	2.23	1.24	0.50	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	0.70	0.70	0.70	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	45.13	2.39	1.71	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	21.01	0.00	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	16.69	0.00	0.00	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.29	0.84	0.84	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	33.67	0.83	0.42	1.66	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	20.98	1.17	0.00	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	34.39	1.51	0.60	0.60	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	40.49	1.25	0.83	2.50	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	28.63	0.00	0.92	1.85	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	27.32	3.41	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.83	1.24	0.28	0.55	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.28	1.81	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	35.18	1.29	0.00	1.29	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.95	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	25.62	0.27	0.00	0.80	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	37.42	1.20	0.30	0.60	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	24.44	1.41	0.28	0.57	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	36.63	1.27	0.96	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.15	1.99	0.22	0.88	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.44	0.38	0.00	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	37.22	1.14	0.57	0.57	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	49.41	1.97	0.25	0.98	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	20.20	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	35.28	0.88	0.29	0.59	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	39.79	1.15	0.86	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	23.08	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	34.54	0.60	0.30	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	37.67	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	74.85	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	65.06	1.31	0.33	0.66	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	93.62	4.21	2.10	2.10	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	72.55	1.78	0.79	0.40	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	67.99	1.86	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	46.19	0.75	0.75	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	59.93	2.13	1.60	0.80	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	38.79	1.13	0.34	0.45	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	61.88	1.47	0.74	1.47	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	55.33	1.10	0.37	0.37	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	49.78	1.56	1.56	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	34.74	0.53	0.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	95.94	1.01	0.00	0.00	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	55.66	4.64	1.69	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	39.50	0.00	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	45.78	3.18	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	34.82	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	37.76	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	5.71	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	0.00	0.00	6.52	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	38.02	0.00	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	87.84	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	31.24	1.29	1.72	0.65	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	20.90	1.05	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	31.37	0.67	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	38.82	2.50	0.83	0.83	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	21.68	0.95	0.00	1.14	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	27.13	3.19	0.00	3.19	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	28.56	0.00	0.68	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.04	1.26	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	33.24	1.16	0.46	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	23.24	0.00	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	19.76	1.26	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	28.79	0.99	0.00	0.50	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	23.01	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	26.52	0.68	0.45	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	21.88	0.49	0.16	0.49	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	27.16	0.36	0.55	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	26.52	0.53	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	13.81	1.80	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	12.47	0.33	0.00	0.00	0.98
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.77	0.65	0.49	0.33	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.81	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	25.32	0.70	0.00	1.41	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	27.58	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	42.42	0.32	1.29	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.28	0.00	0.00	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	22.50	0.22	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	29.64	2.12	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	19.70	0.47	0.24	0.47	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	37.34	1.72	0.43	1.72	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	9.03	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	26.99	0.33	0.33	0.67	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	16.23	1.35	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	25.40	0.79	0.40	0.40	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	33.43	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.84	1.89	0.38	1.51	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.46	1.30	0.33	0.98	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	15.25	0.44	0.87	0.44	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	19.90	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	36.16	4.41	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.26	1.33	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	27.78	1.98	0.50	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	0.00	1.15	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	49.90	1.21	0.60	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.47	1.11	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	25.07	0.68	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	45.12	0.61	1.83	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	31.47	1.26	0.63	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.94	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	24.53	1.58	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	19.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	15.17	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	42.61	1.61	0.62	0.62	0.12
Myoblast, donor2	11322-117D8	44.69	1.73	1.53	0.58	0.19
Myoblast, donor3	11398-118D3	67.60	2.52	1.68	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	66.25	1.17	1.46	0.88	0.15
Natural Killer Cells, donor1	11230-116C6	86.72	3.69	0.31	0.92	0.00
Natural Killer Cells, donor2	11311-117C6	79.01	1.21	1.21	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	87.61	1.29	1.29	0.74	0.00
Neural stem cells, donor1	11275-116H6	41.01	1.81	1.45	0.00	0.00
Neural stem cells, donor2	11352-117H2	21.18	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	67.14	3.41	3.41	0.00	0.00
Neurons, donor2	11574-120E8	58.12	1.98	1.54	1.10	0.22
Neurons, donor3	11655-122E8	69.06	2.47	4.93	0.00	0.82
Neutrophils, donor1	11233-116C9	22.27	0.93	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	31.89	0.00	0.00	0.00	2.90
Neutrophils, donor3	11390-118C4	23.82	1.83	0.61	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	32.41	1.42	0.47	0.36	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	23.12	0.33	0.65	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	13.84	0.60	0.60	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	31.11	0.55	0.69	0.41	0.28
Olfactory epithelial cells, donor2	11934-125I8	30.11	0.14	0.43	1.30	0.29
Olfactory epithelial cells, donor3	11935-125I9	33.82	0.79	1.14	0.34	0.00
Olfactory epithelial cells, donor4	11936-126A1	29.71	0.68	0.39	0.19	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	43.93	3.61	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	31.48	1.06	1.91	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	51.44	4.57	2.29	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	62.07	0.62	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	64.89	3.52	1.76	0.98	0.00
Osteoblast, donor2	11354-117H4	33.01	0.00	0.00	0.70	0.70
Osteoblast, donor3	11426-118G4	54.03	1.42	0.71	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	34.62	2.02	0.34	0.25	0.25
Pericytes, donor1	11491-119E6	25.26	1.22	1.00	0.56	0.11
Pericytes, donor2	11571-120E5	26.26	1.13	0.91	0.68	0.23
Pericytes, donor3	11652-122E5	39.88	2.24	2.03	0.20	0.00
Perineurial Cells, donor1	11499-119F5	30.74	0.79	0.34	0.23	0.00
Perineurial Cells, donor2	11579-120F4	34.41	2.67	1.10	0.18	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	68.21	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	49.95	0.73	0.00	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	62.25	0.78	0.78	0.39	0.00
Placental Epithelial Cells, donor1	11278-116H9	168.61	6.70	2.87	2.15	2.63
Placental Epithelial Cells, donor2	11355-117H5	37.70	1.11	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	57.33	0.98	0.59	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	52.53	4.43	1.58	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	31.89	1.88	1.13	0.38	0.94
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	66.83	2.09	1.31	0.26	0.13
Preadipocyte - breast, donor2	11328-117E5	40.30	1.35	0.90	0.68	0.23
Preadipocyte - omental, donor1	11468-119C1	39.64	1.81	1.17	0.75	0.21
Preadipocyte - omental, donor2	11329-117E6	42.34	3.06	2.62	0.00	0.44
Preadipocyte - omental, donor3	11403-118D8	61.60	2.01	1.29	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	26.58	1.97	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	96.74	5.84	2.76	0.61	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	46.04	2.66	0.53	0.89	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	45.81	2.21	1.36	0.34	0.17
Preadipocyte - visceral, donor1	11280-116I2	41.54	2.70	0.65	1.02	0.09
Preadipocyte - visceral, donor2	11357-117H7	21.17	2.30	0.46	0.92	0.46
Preadipocyte - visceral, donor3	11429-118G7	29.78	1.99	0.63	1.04	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	80.40	3.47	0.91	1.06	1.66
Prostate Epithelial Cells, donor2	11331-117E8	25.46	1.90	0.95	0.95	0.95
Prostate Epithelial Cells, donor3	11404-118D9	48.99	2.51	1.71	0.67	0.18
Prostate Stromal Cells, donor1	11254-116F3	46.93	1.71	0.68	0.34	0.00
Prostate Stromal Cells, donor2	11332-117E9	45.54	0.90	0.72	0.54	0.18
Prostate Stromal Cells, donor3	11405-118E1	28.15	1.56	0.42	0.10	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	41.24	2.55	1.09	0.73	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	22.66	1.25	0.83	0.21	0.00
Renal Epithelial Cells, donor1	11517-119H5	58.84	2.03	2.54	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	48.37	1.42	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	24.45	1.69	0.64	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	27.91	1.36	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	21.56	3.91	0.40	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	22.42	0.44	0.67	0.22	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	55.23	0.67	2.66	3.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	30.59	3.08	1.10	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	25.08	0.63	0.63	0.00	0.63
Renal Mesangial Cells, donor3	11679-122H5	38.28	1.11	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.09	4.56	1.34	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	43.43	1.27	0.42	1.27	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	43.20	2.89	1.35	0.39	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	38.89	1.04	0.52	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	34.68	1.42	0.85	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	39.11	1.03	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	25.34	2.01	0.50	0.50	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	78.31	1.60	0.80	0.80	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	61.64	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	28.62	1.65	0.55	0.55	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	26.10	0.58	0.00	0.58	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	47.72	2.73	0.91	0.65	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	75.77	2.48	0.99	0.79	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	80.42	3.46	1.23	1.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	40.81	2.48	1.24	0.74	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	78.90	3.96	1.86	0.82	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	75.12	2.77	0.92	1.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	33.95	0.96	0.68	0.41	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	75.33	2.57	1.36	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	87.80	3.05	1.97	0.18	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	38.02	2.01	0.57	0.72	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	74.37	1.82	1.29	0.86	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	77.89	2.21	0.44	0.66	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	32.69	0.96	1.34	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	74.44	2.52	1.86	0.75	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	69.34	1.88	1.13	0.38	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	42.86	2.65	1.06	0.80	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	74.37	2.53	0.68	0.49	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	82.49	3.82	1.15	0.76	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	40.80	2.03	1.07	0.75	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	60.83	0.84	0.56	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	67.68	2.22	1.54	1.03	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	41.02	2.37	1.64	0.91	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.65	2.58	0.61	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	85.96	4.16	1.34	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.73	3.07	1.18	0.71	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	78.37	3.37	1.39	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	78.34	3.51	1.87	2.34	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	45.00	2.07	1.24	1.24	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	59.73	1.33	1.11	0.88	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	79.79	2.92	2.92	1.46	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	41.86	2.56	0.40	0.94	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	68.12	2.21	1.87	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	76.54	2.89	1.93	0.77	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	41.44	3.27	0.69	1.03	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	79.28	2.74	2.19	1.10	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	73.06	2.79	1.31	1.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	37.32	2.05	1.02	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	74.87	3.40	0.89	0.59	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	64.77	2.13	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.66	1.94	0.41	0.28	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	75.48	2.86	0.95	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	72.15	3.22	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	47.46	2.73	1.13	1.04	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	68.48	2.10	0.70	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	63.16	2.12	1.21	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	51.16	2.94	0.98	2.08	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	87.77	2.91	1.60	0.73	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	94.31	2.43	0.00	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	47.92	3.62	0.60	1.21	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	117.84	3.62	0.23	1.81	4.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	97.35	1.50	1.20	0.90	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	71.79	2.95	1.65	2.01	5.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	112.91	3.63	0.64	2.13	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	76.32	0.60	1.80	0.60	0.00
Schwann Cells, donor1	11498-119F4	37.24	2.26	1.32	0.38	0.38
Schwann Cells, donor2	11578-120F3	34.02	3.40	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	29.36	1.31	1.10	0.00	0.22
Sebocyte, donor1	11220-116B5	51.49	5.48	1.10	0.00	0.00
Sebocyte, donor2	11301-117B5	33.09	0.46	0.46	0.92	0.00
Sebocyte, donor3	11378-118B1	40.19	1.24	1.86	0.62	0.21
Sertoli Cells, donor1	11255-116F4	39.76	0.00	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	19.77	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	56.39	1.94	1.32	0.26	1.06
Skeletal Muscle Cells, donor2	11358-117H8	51.32	2.89	1.45	0.72	0.00
Skeletal Muscle Cells, donor3	11430-118G8	40.13	1.67	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	29.22	1.89	0.79	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	21.55	0.59	0.74	0.00	0.00
Skeletal Muscle Cells, donor6	11459-119B1	37.71	2.46	1.08	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.15	1.89	0.63	0.50	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.25	1.28	0.71	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	53.87	2.58	0.89	0.40	0.30
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	32.02	1.52	0.93	0.59	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	58.62	3.62	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	24.49	2.20	0.28	0.41	0.00
Skin - palm, donor1	10286-104F7	16.12	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	31.57	2.02	0.72	0.58	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	94.88	7.36	2.45	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	33.63	1.56	0.78	0.52	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	46.57	3.75	1.11	0.70	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	29.54	0.84	0.42	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	197.07	8.88	3.81	0.63	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	50.07	2.25	0.75	0.52	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.94	1.23	0.00	0.31	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	25.35	1.33	0.44	0.44	0.67
Smooth Muscle Cells - Aortic, donor0	11210-116A4	67.01	2.35	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	48.18	2.21	0.22	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	50.40	1.58	1.18	0.79	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	49.44	0.00	0.77	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	45.03	0.00	0.00	0.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.58	3.06	1.46	0.00	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	25.05	1.55	1.33	0.22	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	25.99	2.43	0.77	0.13	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	39.07	2.28	0.33	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	42.53	0.59	0.59	0.30	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	30.18	1.14	0.28	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	48.80	1.95	1.46	0.49	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	19.79	0.30	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	48.49	2.02	0.76	0.51	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	24.32	1.43	1.43	0.95	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	28.02	1.18	0.88	0.29	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.45	0.86	0.22	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	34.01	1.05	0.84	0.10	0.10
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	62.03	4.18	1.08	0.93	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	35.57	4.31	2.16	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	22.41	0.90	0.30	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	39.26	2.05	2.05	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	20.26	0.71	0.24	0.16	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	22.24	0.91	0.60	0.40	1.11
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	39.59	0.91	0.46	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	18.11	1.81	1.81	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	59.61	2.12	2.12	1.06	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.38	0.80	0.53	0.40	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	18.41	1.13	0.38	0.38	0.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	29.42	1.01	1.01	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	35.13	1.96	0.90	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	33.01	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	77.53	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	66.04	1.86	1.86	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	41.40	4.54	1.01	0.00	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	31.34	1.88	0.94	0.94	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	23.60	1.18	1.18	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	36.32	1.58	0.67	0.08	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	22.42	1.40	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	42.46	3.60	1.15	0.43	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	52.52	2.80	0.76	0.51	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	26.51	1.50	0.56	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	19.01	2.10	0.42	0.28	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	24.63	0.59	0.42	0.08	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	37.14	1.43	0.95	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	42.82	2.94	0.98	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	22.32	1.55	0.22	0.66	0.66
Smooth Muscle Cells - Uterine, donor3	11466-119B8	43.59	2.05	0.88	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.63	1.17	0.39	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	21.16	1.06	0.26	0.00	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	8.93	0.37	0.37	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	23.36	0.36	1.44	0.00	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	30.66	0.85	0.57	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.81	1.18	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.73	0.76	0.00	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	16.37	0.40	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	23.83	1.25	1.25	0.00	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	35.29	1.38	0.00	0.00	0.92
Synoviocyte, donor1	11291-117A4	26.76	1.18	1.01	0.67	0.17
Synoviocyte, donor2	11368-117I9	32.18	0.17	0.34	0.50	0.00
Synoviocyte, donor3	11440-118H9	17.20	0.67	0.22	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	54.67	3.57	1.07	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	57.48	1.98	0.00	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	51.17	1.39	0.93	0.23	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	63.80	3.94	1.29	0.36	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	56.44	2.71	0.00	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	37.22	2.29	2.86	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	86.73	1.85	1.23	0.49	1.48
Urethra, donor2	10319-105A4	14.39	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	46.76	2.39	1.86	0.00	0.00
Urothelial Cells, donor2	11600-120H7	36.05	1.60	1.20	0.00	0.40
Urothelial Cells, donor3	11681-122H7	52.95	2.29	0.46	0.46	0.00
Urothelial cells, donor0	11216-116B1	45.92	1.78	0.89	0.67	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	26.69	0.89	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	2.86	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.76	0.00	0.00	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	66.11	0.69	1.72	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	55.20	1.16	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	40.61	2.08	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.94	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	51.12	2.74	0.91	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	52.43	1.48	0.49	0.25	0.12
Wilms' tumor cell line:HFWT	10597-108E3	38.72	1.76	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	43.57	1.40	0.28	0.28	0.00
achilles tendon, donor2	10292-104G4	22.73	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	80.06	3.82	1.78	1.53	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	87.53	2.79	1.86	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	52.59	1.07	1.42	0.24	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	51.43	0.54	1.09	2.72	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.74	1.69	2.25	1.12	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	107.43	2.96	2.96	0.42	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	60.70	4.08	1.91	2.45	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	75.79	1.76	3.08	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	79.22	2.86	2.04	1.23	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	111.83	1.55	3.11	1.94	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	71.21	4.05	1.10	2.39	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	70.21	3.90	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	65.30	1.63	1.39	2.32	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	75.60	2.59	1.55	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	81.83	1.75	1.46	1.46	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	52.98	1.86	0.46	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.90	1.65	1.23	1.23	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	112.34	3.38	1.23	2.76	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	142.09	4.27	0.85	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	115.86	3.64	1.52	1.21	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	116.98	3.13	2.89	0.72	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	56.58	3.12	0.89	1.56	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	24.68	0.67	0.33	1.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	52.03	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	95.67	3.39	1.88	1.51	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	44.92	0.44	0.00	0.87	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	11.25	3.75	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	75.83	1.18	0.71	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	35.83	0.47	0.47	0.93	0.16
adipose, donor1	10184-103D4	30.49	1.17	0.00	1.17	2.93
adipose, donor2	10185-103D5	31.63	2.03	0.81	0.00	2.03
adipose, donor3	10186-103D6	42.20	1.09	1.63	0.00	1.36
adipose, donor4	10187-103D7	36.40	1.73	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	63.13	1.58	0.95	0.79	0.00
adrenal gland, adult, pool1	10081-102A9	54.57	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	78.71	7.07	3.07	3.20	0.53
alveolar cell carcinoma cell line:SW 1573	10708-109H6	91.11	2.14	0.36	0.71	0.71
amniotic membrane cells, donor1	12235-129G3	58.19	1.85	0.70	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	47.33	2.03	1.69	0.00	1.01
amniotic membrane cells, donor3	12237-129G5	19.44	1.18	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	28.46	0.00	0.00	2.37	0.00
amygdala, adult, donor10252	10151-102I7	56.77	1.01	0.61	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	28.40	1.61	0.97	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	27.63	1.27	0.76	0.25	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	91.34	3.31	1.32	1.32	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	65.47	1.34	1.00	1.67	0.00
aorta, adult, pool1	10052-101G7	31.97	0.78	0.39	0.20	0.00
appendix, adult	10189-103D9	60.93	2.33	0.78	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	58.81	1.38	0.00	0.69	1.03
artery, adult	10190-103E1	32.61	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	69.39	1.88	1.16	0.72	0.14
b cell line:RPMI1788	10427-106D4	63.64	1.93	0.89	0.89	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	38.84	1.94	0.55	0.83	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	47.14	1.79	0.60	0.30	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	61.26	1.51	0.33	0.50	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	62.63	3.91	2.24	1.12	0.00
bladder, adult, pool1	10011-101C2	35.96	0.98	0.98	0.33	0.43
blood, adult, pool1	10053-101G8	48.72	0.00	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	36.82	0.00	0.86	0.00	0.00
bone marrow, adult	10192-103E3	35.09	2.70	0.00	0.67	0.67
brain, adult, donor1	10084-102B3	51.25	3.08	0.00	1.03	0.00
brain, adult, pool1	10012-101C3	29.84	1.78	0.67	0.33	0.67
brain, fetal, pool1	10085-102B4	58.77	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	34.69	1.65	0.33	0.99	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	47.31	1.87	1.00	0.50	0.00
breast, adult, donor1	10080-102A8	53.67	2.53	0.63	0.63	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	62.38	1.40	0.51	0.38	0.25
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	76.07	2.78	0.62	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	29.47	1.84	0.46	1.84	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	36.80	1.21	0.24	0.97	0.00
carcinoid cell line:NCI-H1770	10703-109H1	91.68	2.82	2.82	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	73.94	2.95	2.52	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	40.25	1.27	0.32	0.63	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	70.54	3.99	2.13	0.53	0.80
caudate nucleus - adult, donor10196	10177-103C6	31.09	2.30	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.38	0.67	0.33	0.50	0.17
caudate nucleus, adult, donor10258	10379-105H1	33.62	1.53	0.00	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	28.57	0.37	1.10	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	61.18	2.91	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	96.51	2.35	1.49	0.43	1.49
cerebellum, adult, pool1	10083-102B2	45.19	1.38	0.34	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	73.07	1.66	4.15	0.83	0.00
cerebral meninges, adult	10188-103D8	25.97	0.00	1.01	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	10.96	0.73	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	81.24	4.17	2.44	1.29	0.14
cervical cancer cell line:ME-180	10553-107I4	57.34	1.82	0.66	0.66	0.17
cervix, adult, pool1	10013-101C4	45.36	1.15	1.05	0.10	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	43.61	1.11	0.14	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	20.90	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	69.84	3.48	2.61	1.12	1.62
choriocarcinoma cell line:SCH	10785-110H2	81.07	3.45	1.60	0.74	0.25
choriocarcinoma cell line:T3M-3	10618-108G6	79.69	1.90	1.42	1.90	0.47
chorionic membrane cells, donor1	12238-129G6	51.86	0.85	1.14	0.28	0.57
chorionic membrane cells, donor2	12239-129G7	52.60	1.29	0.50	0.30	0.70
chorionic membrane cells, donor3	12240-129G8	24.73	1.10	0.55	0.55	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	24.24	0.00	0.00	2.02	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	71.84	2.69	1.54	0.58	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	71.38	1.90	0.00	1.90	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	42.89	1.28	0.51	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	47.89	0.73	0.73	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	48.26	1.02	1.02	0.61	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	89.51	1.47	0.59	1.47	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	73.24	1.30	0.00	0.78	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	39.09	0.69	0.23	0.46	0.00
clear cell carcinoma cell line:TEN	10636-108I6	40.25	1.39	0.69	0.52	0.17
colon carcinoma cell line:CACO-2	10513-107D9	88.41	2.56	0.55	0.37	0.37
colon carcinoma cell line:COLO-320	10420-106C6	79.06	3.04	1.52	1.14	0.00
colon, adult, donor1	10082-102B1	92.82	1.19	1.19	3.57	0.00
colon, adult, pool1	10014-101C5	73.20	1.06	0.59	0.59	0.94
colon, fetal, donor1	10070-101I7	55.62	1.24	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	187.92	4.58	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	71.39	3.40	2.97	1.70	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	61.73	4.23	1.66	0.91	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	65.29	3.53	1.97	1.41	0.00
corpus callosum, adult, pool1	10042-101F6	61.91	1.88	1.33	0.11	0.11
cruciate ligament, donor2	10295-104G7	25.12	0.00	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	42.54	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	22.80	0.48	0.48	0.00	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	56.03	2.76	1.38	2.07	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	52.57	2.82	1.80	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	99.42	6.98	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	59.30	1.99	0.50	0.00	1.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	66.25	1.44	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	37.52	1.47	0.74	0.74	1.47
dura mater, adult, donor1	10041-101F5	45.26	1.24	1.40	0.17	0.08
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	127.03	15.32	7.55	9.10	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	77.24	6.16	2.87	1.00	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	59.81	1.85	0.00	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.01	1.51	0.91	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	54.65	2.16	0.00	0.93	0.31
embryonic pancreas cell line:2C6	10603-108E9	61.73	2.63	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	56.31	2.01	1.01	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	111.28	3.44	2.72	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	41.65	1.29	1.13	0.96	0.32
epidermoid carcinoma cell line:A431	10426-106D3	38.68	1.33	0.67	0.56	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	61.37	2.31	2.53	1.54	0.22
epididymis, adult	10197-103E8	33.49	1.05	0.42	0.42	1.26
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	54.29	1.77	0.71	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	36.18	0.79	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	94.75	3.54	0.52	1.97	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	81.79	1.67	0.49	1.08	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	103.18	3.70	0.78	1.79	0.34
esophagus, adult, pool1	10015-101C6	44.38	1.81	1.38	0.42	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	57.11	1.13	0.50	0.13	0.00
eye - muscle inferior rectus, donor1	10272-104E2	19.32	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	20.84	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	12.61	0.00	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	20.40	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	39.66	0.25	0.00	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	47.06	2.18	0.64	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	63.87	2.37	0.71	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	38.19	0.56	1.13	0.38	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	108.69	2.40	0.60	1.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	49.65	1.10	0.55	0.09	0.00
gall bladder, adult	10198-103E9	38.15	1.21	0.72	0.48	1.21
gamma delta positive T cells, donor1	11937-126A2	115.42	1.61	1.07	0.54	0.00
gamma delta positive T cells, donor2	11938-126A3	106.45	3.73	0.75	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.32	2.53	0.84	0.42	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	78.14	0.77	0.39	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	76.08	2.30	0.49	0.33	0.16
gastric cancer cell line:GSS	10560-108A2	93.35	2.75	0.92	0.92	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	40.89	0.91	1.14	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	55.53	2.41	1.03	0.80	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	75.02	3.22	0.70	0.42	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	38.66	1.50	1.00	0.75	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.98	1.16	1.37	0.53	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.05	2.25	0.98	0.70	0.14
glioblastoma cell line:T98G	10485-107A8	46.91	1.32	1.32	0.66	0.11
glioma cell line:GI-1	10413-106B8	43.35	1.17	0.29	0.00	0.59
globus pallidus - adult, donor10196	10175-103C4	45.19	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	87.14	0.98	0.98	0.49	0.00
globus pallidus, adult, donor10258	10367-105F7	21.91	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	37.84	1.07	1.60	1.60	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	274.08	0.00	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	21.86	10.93	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	125.44	5.23	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	16.32	0.64	0.32	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	28.01	0.46	0.46	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	23.78	2.74	0.00	0.91	0.00
hIPS +CCl2, biol_rep3	14385-156C2	25.76	1.93	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	11.50	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	29.49	3.43	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	11.03	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	61.78	3.16	0.29	1.72	0.00
heart - mitral valve, adult	10205-103F7	30.79	0.30	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	22.75	0.00	0.52	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	67.44	1.67	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	53.05	0.82	1.22	0.00	0.00
heart, adult, diseased, donor1	10051-101G6	41.31	0.43	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	35.42	1.15	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	49.39	1.33	1.03	0.10	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	29.31	0.93	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	3.57	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	129.94	5.08	1.66	1.99	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	120.89	3.40	0.97	1.82	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	130.06	4.65	0.71	1.11	0.10
hepatoma cell line:Li-7	10484-107A7	61.95	1.56	0.56	0.33	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	49.35	1.71	0.70	0.40	0.10
hippocampus - adult, donor10196	10169-103B7	28.39	0.95	0.00	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	55.11	1.02	0.61	0.20	0.00
hippocampus, adult, donor10258	10374-105G5	15.93	0.00	0.00	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	26.79	0.00	0.70	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	52.49	1.22	0.61	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	50.07	1.57	0.79	1.37	0.79
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	54.08	2.03	1.78	1.27	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	45.67	1.13	0.00	0.00	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	40.54	1.81	0.52	0.77	3.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	48.59	1.90	0.38	0.00	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	34.45	0.88	0.58	0.88	1.75
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	43.95	1.72	0.00	2.15	2.59
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	42.12	2.09	1.25	0.83	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	51.15	2.13	1.42	0.24	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	52.23	1.61	1.29	1.13	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	70.70	2.69	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	48.20	1.41	0.47	0.94	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	35.37	0.49	1.47	1.47	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.06	0.87	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	51.16	2.10	0.38	1.15	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.99	2.62	0.44	0.44	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	46.98	1.50	1.00	0.00	3.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	30.90	1.70	0.57	0.94	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	35.47	0.91	1.36	0.00	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	32.26	2.19	1.25	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	43.27	1.47	2.29	0.82	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	38.61	1.74	0.58	0.58	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	40.35	2.09	0.90	1.49	1.49
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	48.22	1.29	0.37	1.29	0.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	47.93	2.28	0.57	1.14	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	64.51	2.04	1.22	2.04	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	39.43	0.70	0.35	1.41	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.18	1.27	0.63	0.63	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	53.87	1.51	1.21	1.51	1.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	34.65	1.55	1.03	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	43.17	1.33	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	34.89	1.28	0.77	0.51	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	44.99	3.07	1.02	0.26	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	36.35	0.76	2.27	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	44.70	1.01	1.68	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	50.23	1.93	0.72	1.21	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	45.46	2.23	0.45	1.78	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	48.29	0.49	0.00	0.98	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	34.23	1.83	1.22	0.61	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	9.76	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	30.45	0.66	0.99	0.99	4.96
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	41.59	2.19	1.09	1.64	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.41	1.45	1.09	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	37.72	1.42	1.42	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	1.19	1.19	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	39.68	2.71	1.63	0.27	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	40.14	1.89	1.08	0.54	1.35
immature langerhans cells, donor1	11904-125F5	41.89	1.21	0.73	0.73	0.00
immature langerhans cells, donor2	11905-125F6	44.36	0.79	0.79	0.00	0.00
insula, adult, pool1	10039-101F3	44.38	1.42	1.70	0.38	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	103.40	3.25	2.60	1.95	0.00
kidney, adult, pool1	10017-101C8	57.07	1.50	1.20	0.20	0.30
kidney, fetal, pool1	10045-101F9	61.47	2.19	1.13	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	34.51	1.14	0.71	0.28	0.14
large cell lung carcinoma cell line:NCI-H460	10839-111E2	47.00	2.90	0.55	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	53.40	1.83	0.92	0.37	0.37
left atrium, adult, donor1	10079-102A7	16.89	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	25.79	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	59.65	0.82	0.00	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	30.18	0.36	0.36	0.72	0.72
leiomyoma cell line:15242A	10570-108B3	23.37	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	25.01	0.73	0.73	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	50.79	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	24.05	1.05	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	97.63	2.48	0.83	3.19	0.00
liposarcoma cell line:KMLS-1	10782-110G8	61.08	1.25	0.94	1.25	0.16
liposarcoma cell line:SW 872	10726-110A6	39.11	1.34	0.49	0.37	0.00
liver, adult, pool1	10018-101C9	99.67	1.13	0.81	1.13	3.08
liver, fetal, pool1	10086-102B5	63.03	0.00	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	33.83	0.87	0.58	0.29	0.15
locus coeruleus, adult, donor10252	10165-103B3	59.98	0.92	1.11	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	51.63	0.56	0.56	1.41	0.28
locus coeruleus, newborn, donor10223	10362-105F2	27.34	0.42	0.42	2.10	1.68
lung adenocarcinoma cell line:A549	10499-107C4	78.33	3.88	0.83	0.83	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	34.47	2.76	0.00	0.69	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	31.11	0.79	0.40	0.13	0.13
lung, adult, pool1	10019-101D1	42.05	1.06	0.59	0.12	0.71
lung, fetal, donor1	10068-101I5	26.26	1.14	0.57	0.57	0.86
lung, right lower lobe, adult, donor1	10075-102A3	44.91	0.92	0.92	0.92	0.92
lymph node, adult, donor1	10077-102A5	48.76	2.37	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	110.25	3.29	0.22	1.53	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	68.82	2.26	1.51	0.75	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	80.70	4.25	0.00	0.85	0.00
mature adipocyte, donor1	12231-129F8	49.28	0.89	0.89	0.00	0.00
mature adipocyte, donor2	12232-129F9	43.37	0.83	0.42	0.21	0.00
mature adipocyte, donor3	12233-129G1	37.46	0.71	0.47	0.24	0.00
mature adipocyte, donor4	12234-129G2	39.22	0.79	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	89.82	3.81	0.95	0.24	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	20.30	1.13	0.00	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	46.71	0.92	0.37	0.37	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	27.32	0.64	1.27	0.32	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	16.63	0.43	1.28	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	36.11	1.35	1.01	1.01	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	54.97	1.06	0.42	0.21	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.56	1.79	0.72	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	45.43	1.30	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	60.06	2.01	0.93	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	42.28	2.04	1.63	0.33	0.00
medulla oblongata, newborn, donor10223	10361-105F1	52.77	2.78	1.04	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	53.80	2.44	1.33	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	45.36	2.08	0.61	0.37	0.00
melanoma cell line:COLO 679	10514-107E1	56.78	2.87	1.72	0.72	0.57
melanoma cell line:G-361	10465-106H6	48.32	2.17	0.54	0.54	1.36
meningioma cell line:HKBMM	10691-109F7	37.63	1.09	0.72	0.18	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	58.16	0.88	0.88	1.76	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	78.54	3.63	2.59	0.26	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	25.32	3.07	0.46	0.46	0.00
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.81	1.09	0.18	0.36	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	11.59	1.24	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	21.77	1.12	0.28	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.41	0.96	0.39	0.58	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	24.99	0.69	2.08	2.08	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	28.49	1.89	0.69	1.03	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	15.30	1.15	0.69	0.23	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	20.96	1.86	0.40	0.66	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	30.52	1.89	0.27	0.68	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	16.64	1.71	0.43	0.43	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	30.96	1.98	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.59	1.11	0.55	0.28	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	30.72	1.75	0.70	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	13.27	1.22	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	19.77	2.16	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	14.28	0.93	0.31	0.62	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.92	2.05	0.00	0.00	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	14.68	0.84	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.53	2.69	0.45	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.34	1.66	0.18	0.70	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	37.55	3.31	0.37	0.74	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	23.46	1.14	0.00	0.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	44.63	2.11	0.84	1.26	0.84
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	24.66	0.91	0.46	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	28.65	1.53	1.28	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	21.99	1.57	0.26	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.34	1.54	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	30.13	0.71	1.18	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	29.45	1.69	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	38.12	1.57	0.39	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	20.39	1.39	1.39	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	32.59	3.46	0.58	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.23	2.01	0.89	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.36	0.96	0.96	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	24.20	1.47	0.73	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	23.50	1.34	0.67	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	19.24	2.05	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	24.48	0.86	0.86	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.01	0.32	0.65	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	24.73	4.36	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	30.92	1.60	0.00	0.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	24.53	2.45	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.82	1.94	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	30.80	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	33.37	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	20.16	2.96	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	35.34	2.44	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	24.70	0.63	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	26.56	1.38	0.34	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	32.24	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	68.88	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	46.45	0.41	1.22	0.81	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	52.43	0.79	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	53.65	1.77	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	54.55	0.94	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	50.79	0.00	1.34	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	56.77	2.37	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	64.20	0.00	0.00	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	52.32	3.44	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	78.67	2.97	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	75.14	1.12	0.00	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	68.06	1.91	1.91	0.64	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	122.10	2.01	1.61	0.00	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	109.03	4.36	6.54	0.00	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	91.23	3.80	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	57.05	0.61	1.21	0.61	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	0.00	4.52	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	110.37	2.47	1.65	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	59.33	2.18	0.60	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	58.41	3.24	2.60	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	49.91	1.02	4.07	2.04	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	26.31	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	78.20	1.42	0.47	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	54.44	0.23	0.70	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	34.32	1.34	0.21	0.82	0.10
mesothelioma cell line:Mero-25	10850-111F4	56.06	4.99	1.13	0.91	0.45
mesothelioma cell line:Mero-41	10851-111F5	44.25	1.22	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	27.46	2.88	0.66	1.11	0.00
mesothelioma cell line:Mero-82	10853-111F7	48.88	0.53	0.79	1.05	0.00
mesothelioma cell line:Mero-83	10854-111F8	50.39	1.36	1.19	0.85	0.85
mesothelioma cell line:Mero-84	10855-111F9	36.15	1.01	0.51	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	32.71	0.62	1.24	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	69.08	5.30	2.98	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	44.70	1.63	0.54	0.90	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	36.39	1.37	0.17	1.02	0.00
mesothelioma cell line:NCI-H28	10845-111E8	36.13	1.53	0.51	0.25	0.00
mesothelioma cell line:No36	10857-111G2	37.51	2.94	0.65	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	29.53	1.63	0.27	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	20.34	0.00	0.58	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	39.32	0.98	0.98	0.37	0.00
migratory langerhans cells, donor3	11903-125F4	24.77	1.08	0.54	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	33.63	2.29	0.65	0.98	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	43.23	2.12	0.21	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.26	1.15	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	62.04	3.04	0.95	1.33	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	105.70	4.99	2.22	1.29	0.74
myeloma cell line:PCM6	10474-106I6	89.15	1.19	0.00	0.99	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	33.99	0.00	0.00	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	59.04	2.35	0.98	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	70.42	4.35	2.56	0.45	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	78.98	4.04	2.06	0.81	0.15
nasal epithelial cells, donor2	12227-129F4	54.09	2.76	3.31	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	98.47	3.91	2.99	0.23	0.69
neuroblastoma cell line:NB-1	10539-107G8	80.07	4.86	2.81	0.75	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	66.01	1.27	0.42	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	74.73	5.03	1.49	0.75	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.86	0.95	1.19	1.66	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	40.70	1.90	1.43	0.79	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	103.85	3.02	2.62	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	36.24	0.64	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.16	0.00	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	133.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	92.96	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	66.29	0.00	9.47	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	132.59	4.06	1.35	1.35	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	127.28	4.80	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	38.15	0.64	0.32	0.32	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	27.85	0.79	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	40.78	1.12	0.75	0.66	0.09
occipital cortex - adult, donor10196	10172-103C1	37.09	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	69.77	1.88	0.27	0.27	0.81
occipital cortex, newborn, donor10223	10355-105E4	20.38	0.73	0.73	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	39.36	1.57	0.26	0.52	1.05
occipital lobe, fetal, donor1	10073-102A1	57.93	1.72	2.15	0.86	0.43
occipital pole, adult, pool1	10036-101E9	44.70	2.05	1.73	0.32	0.00
olfactory region, adult	10195-103E6	25.41	0.76	1.15	0.19	0.38
optic nerve, donor1	10277-104E7	34.02	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	59.12	2.05	0.68	1.37	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	58.80	1.65	0.69	0.55	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	30.14	0.51	0.51	0.68	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	62.49	1.50	1.27	1.27	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	33.51	0.59	0.59	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	75.68	2.80	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	77.19	3.18	2.54	0.42	0.00
ovary, adult, pool1	10020-101D2	35.20	0.79	0.70	0.26	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.28	2.02	1.65	0.18	0.00
pancreas, adult, donor1	10049-101G4	95.95	1.88	0.94	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	65.13	2.80	0.28	1.96	0.56
papillary adenocarcinoma cell line:8505C	10437-106E5	27.77	1.36	0.51	0.34	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	54.15	1.66	1.32	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	36.15	1.56	0.82	0.55	0.09
parietal cortex, adult, donor10258	10373-105G4	13.21	0.00	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	40.44	0.00	0.94	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	40.76	2.00	0.29	0.86	0.29
parietal lobe, adult, pool1	10034-101E7	45.73	1.76	1.06	0.53	0.00
parietal lobe, fetal, donor1	10072-101I9	32.97	1.94	0.97	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	20.56	0.37	0.75	0.75	0.00
parotid gland, adult	10199-103F1	57.97	2.47	0.00	0.62	0.00
penis, adult	10200-103F2	30.08	0.00	0.54	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	47.97	1.30	1.67	1.12	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	47.06	0.73	0.73	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	32.90	0.65	0.00	0.65	0.00
pineal gland, adult, donor10252	10160-103A7	59.81	0.59	1.18	0.00	0.59
pineal gland, adult, donor10258	10377-105G8	28.85	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	46.54	1.01	1.01	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	85.47	2.61	2.08	0.00	0.52
pituitary gland, adult, donor10258	10378-105G9	49.37	0.85	0.00	0.00	1.70
placenta, adult, pool1	10021-101D3	56.87	1.40	1.51	0.65	0.43
plasma cell leukemia cell line:ARH-77	10840-111E3	40.39	1.85	1.85	1.06	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	40.31	1.71	0.31	0.16	0.16
pons, adult, pool1	10033-101E6	32.19	1.55	1.89	0.43	0.09
postcentral gyrus, adult, pool1	10032-101E5	40.36	1.05	1.39	0.78	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	207.05	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	64.53	2.62	1.02	0.73	0.15
prostate cancer cell line:PC-3	10439-106E7	95.11	2.54	1.09	1.09	0.00
prostate, adult, pool1	10022-101D4	42.63	1.27	0.63	0.18	0.63
putamen, adult, donor10196	10176-103C5	45.80	0.47	0.24	0.94	0.00
putamen, adult, donor10252	10152-102I8	43.14	0.00	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	7.65	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	22.71	1.21	0.72	0.48	0.00
putamen, newborn, donor10223	10365-105F5	9.00	0.00	0.75	1.50	0.00
rectal cancer cell line:TT1TKB	10469-106I1	49.75	0.58	1.45	1.45	0.00
rectum, fetal, donor1	10067-101I4	65.38	0.00	1.39	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	43.46	1.27	0.42	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	46.39	2.49	1.24	0.83	0.00
retina, adult, pool1	10030-101E3	53.08	0.99	0.99	0.20	0.00
retinoblastoma cell line:Y79	10475-106I7	90.41	1.56	1.04	0.78	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.11	1.48	0.61	0.37	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	108.26	2.53	1.12	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	0.00	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	29.13	0.81	0.81	0.65	0.16
salivary acinar cells, donor2	11772-123I8	31.67	1.79	1.10	0.69	0.28
salivary acinar cells, donor3	11773-123I9	39.72	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	45.76	0.57	0.57	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	50.59	1.77	1.26	0.93	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.94	2.70	2.12	1.06	0.00
seminal vesicle, adult	10201-103F3	47.62	1.59	1.06	0.53	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.78	1.46	0.73	0.97	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	35.23	2.01	1.76	0.50	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	38.13	0.00	2.01	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	73.20	3.22	2.55	0.94	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	56.59	1.66	1.33	0.77	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	101.41	1.55	0.52	0.52	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	14.90	0.71	0.71	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	56.25	1.68	0.36	0.12	1.08
skeletal muscle, fetal, donor1	10066-101I3	34.17	1.01	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	46.71	0.63	0.00	1.26	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	92.39	3.00	2.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.89	3.47	1.26	1.89	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	94.64	2.51	1.73	1.35	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	88.68	4.29	1.15	0.49	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	64.50	4.83	1.77	0.64	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	63.85	2.40	1.31	1.09	0.00
small intestine, adult, pool1	10024-101D6	117.77	1.91	1.43	0.72	1.79
small intestine, fetal, donor1	10064-101I1	48.89	1.23	0.98	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	56.93	2.05	0.51	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	31.53	0.52	0.52	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	44.22	1.34	0.54	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	40.15	0.69	0.46	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	48.50	1.18	2.37	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	17.29	1.38	0.00	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	78.06	0.61	1.83	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	54.65	1.84	1.38	1.84	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	26.44	1.19	0.45	0.15	0.15
spleen, adult, pool1	10025-101D7	52.31	1.65	1.10	0.22	0.33
spleen, fetal, pool1	10044-101F8	67.06	1.83	0.79	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	52.27	1.55	0.83	1.24	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	77.28	1.90	0.19	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	37.74	1.05	1.40	1.40	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	30.88	3.52	1.17	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	34.67	1.58	1.01	0.56	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	51.68	0.00	1.27	1.27	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	43.58	0.85	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	55.53	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	58.11	2.28	1.71	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	69.17	2.28	0.83	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	12.93	2.07	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	43.10	0.71	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	74.05	2.98	1.38	0.46	0.00
temporal lobe, adult, pool1	10031-101E4	46.03	1.10	0.85	0.68	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	59.83	2.85	3.56	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	30.77	2.64	0.88	0.44	0.00
tenocyte, donor1	11763-123H8	33.51	1.75	1.05	0.35	0.00
tenocyte, donor2	11765-123I1	39.30	0.76	1.53	1.53	0.38
tenocyte, donor3	11768-123I4	26.32	1.85	1.48	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	53.88	2.04	0.85	1.36	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	56.57	2.00	0.92	0.46	0.15
teratocarcinoma cell line:PA-1	10807-111A6	55.33	2.32	0.77	0.46	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	51.29	1.14	0.89	0.76	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	59.37	0.38	0.76	1.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	22.14	1.42	0.55	0.65	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	62.21	2.28	2.28	2.61	0.33
testis, adult, pool1	10026-101D8	53.58	1.72	1.18	0.43	4.94
testis, adult, pool2	10096-102C6	46.01	1.80	2.26	0.00	0.00
thalamus - adult, donor10196	10168-103B6	45.26	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	59.07	1.72	0.16	0.31	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	10.78	0.00	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	31.46	0.82	0.99	0.66	0.00
thalamus, newborn, donor10223	10366-105F6	18.41	1.15	0.58	1.73	0.00
throat, adult	10209-103G2	39.70	1.00	0.75	0.00	0.00
throat, fetal, donor1	10061-101H7	52.41	0.91	0.30	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	47.50	1.99	0.79	0.60	0.20
thymus, adult, pool1	10027-101D9	44.64	0.60	0.89	0.60	0.60
thymus, fetal, pool1	10043-101F7	62.24	1.04	0.73	0.52	0.42
thyroid carcinoma cell line:KHM-5M	10776-110G2	36.83	1.60	1.33	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	43.58	2.10	0.84	0.70	0.14
thyroid, adult, pool1	10028-101E1	65.60	1.40	0.56	0.56	0.65
thyroid, fetal, donor1	10060-101H6	68.55	1.05	0.79	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	30.93	1.40	0.70	0.23	0.00
tongue, fetal, donor1	10059-101H5	53.60	1.18	1.58	0.39	0.00
tonsil, adult, pool1	10047-101G2	72.63	1.30	2.20	1.00	0.00
trachea, adult, pool1	10029-101E2	61.35	1.23	0.74	0.74	0.57
trachea, fetal, donor1	10058-101H4	65.01	0.77	0.00	0.38	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.47	1.42	1.06	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	63.42	2.84	1.01	1.11	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	77.87	3.45	2.19	1.88	0.78
tridermal teratoma cell line:HGRT	10694-109G1	22.83	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	47.49	2.03	0.59	0.42	0.08
umbilical cord, fetal, donor1	10057-101H3	33.38	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	17.57	0.34	0.68	0.00	0.34
uterus, fetal, donor1	10055-101H1	56.31	1.54	0.51	0.00	0.00
vagina, adult	10204-103F6	29.08	1.29	0.65	0.00	0.00
vein, adult	10191-103E2	39.89	0.44	0.44	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	39.52	1.60	0.53	0.53	0.00